Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-01-15
2000-05-30
Criares, Theodore J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514725, 424702, A01N 4316, A01N 3104, A01N 5902
Patent
active
060691670
ABSTRACT:
The present invention relates to formulations and methods for preventing and treating liver injury and fibrosis in cholestasis. This is accomplished by the administration of a composition which includes selected antioxidants.
REFERENCES:
patent: 4619829 (1986-10-01), Motschan et al.
patent: 5326757 (1994-07-01), Demopoulos
patent: 5332579 (1994-07-01), Umbdenstock
patent: 5364644 (1994-11-01), Walaszek et al.
Sokol, Ronald J., et al. Evidence for Involvement of Oxygen Free Radicals in Bile Acid Toxicity to Isolated Rat Hepatocytes, Hepatology (1993)17:869-881.
Sokol, Ronald J., et al. Effect of Dietary Lipid Peroxidation and Hepatic Injury in the Bile Duct-Ligated Rat, Journal of Lipid Research(1991) 32:13491357.
Sokol,Ronald J., et al. Generation of Hydroperoxides in Isolated Rat Hepatocytes and Hepatic Mitochondria Exposed to Hydrophobic Bile Acids, Gastroenterology (1995) 109:1249-1256.
Sokol, Ronald J., et al. Multicenter Trial of d-a-Tocopheryl Polyethylene Glycol 1000 Succinate for Treatment of Vitamin E Deficiency in Children with Chronic Cholestasis, Gastroenterology (1993)104:1727-35.
Sokol, Ronald J., et al. Treatment of Vitamin E Deficiency During Chronic Childhood Cholestasis with Oral d-a-Tocopheryl Polyethylene Glycol-1000 Succiante, Gastroenterology (1987) 93:975-85.
Sokol, Ronald J., et al. Tocopheryl Polyethylene Glycol 1000 Succinate therapy for Vitamin E Deficiency During Chronic Childhood Cholestasis: Neurologic Outcome, J. of Pediatrics (1987) 3:830-836.
Sokol, Ronald J., et al. Improvement of Cyclosporin Absorption in Children after Liver Transplantation by Means of Water-Soluble Vitamin E, The Lancet (1991) 338:212-216.
Sokol, R.J., et al. Evidence of Free Radical Generation in Bile Acid Toxicity to Isolated Rat Hepatocytes, Abstract Amer. Assn. for the Study of Liver Diseases, Chicago, IL Oct. 31, 1992.
Sokol, Ronald J., et al. Free Radical Alteration of Hepatic Mitochondrial Lipids in End-Stage Liver Disease, Abstract Amer. Pediatric Society, Society for Pediatric Research, 1993, Abstract 25524.
Sokol, R.J., et al. Taurochenodeoxycholic acid Hepatotoxicity is Associated with Hepatocyte Hydroperoxide Generation and Mitochondrial Lipid Peroxidation, Abstract Joint Meeting of North Amer. Society for Pediatric Gastroenterology and Nutrition and the European Society for Paediatric Gastroenterology and Nutrition, Houston, TX, Oct. 10, 1994.
Sokol, R.J., et al. Vitamin E Reduces Oxidant Injury to Hepatic Mitochondria Caused by Intravenous Taurochenodeoxycholic Acid in the Rat, Abstract Amer. Liver Foundation, Chicago, IL Nov. 11, 1994.
Goff, M.C., et al. Mitochondrial Lipid Peroxidation Accompanies Intravenous Taurochenodeoxycholic Acid-Induced Hepatic Injury in the Rat, Abstract Amer. Gastroenterological Assn., New Orleans, LA, May 15, 1994.
Winklhofer-Roob, B.M., et al. Increased Generation of Hydrogen Peroxide by Isolated Rat Hepatic Mitochondria Exposed to Chenodeoxycholic Acid, Abstract Amer. Assn. for the Study of Liver Diseases, Chicago, IL Nov. 11, 1994.
Shivaram, K., et al. Idebenone Inhibits Taurochenodeoxycholic Acid Toxicity and Reduces Oxidant Stress in Isolated Rat Hepatocytes, Abstract Meetings of the AGA, AASLD at Digestive Disease Week, San Diego, CA May 14, 1995.
Winklhofer-Roob, B.M., et al. Dose-Dependent Increase in Hydrogen Peroxide Generation by Rat Hepatic Mitochondria Exposed to Chenodeoxycholic Acid and its Attenuation by Catalase, Abstract North Amer. Society for Pediatric Gastroenterology and Nutrition, Chicago, IL Nov. 3, 1995.
Database CAPLUS on STN, Abstract No. 1993:508953,Chen,H. et al., Protection by vitamin E, Selenium, and Beta-carotene Against Oxidative Damage in Rat Liver Slices and Homogenate, abstract Free Radical Bio. Med., 14(5), 1993.
Database WPIDS on STN, Abstract No. 95-044272, PLOCH, Capsule for Active Detoxification of Body Cells Contg. Vitamin E, Beta Carotene, Selenium and Zinc as Free Radical Scavengers, abstract, DE 4322070 A1 (Ploch E. M.) Jan. 12, 1995.
Database CAPLUS on STN, Abstract No. 1995:4707993, Chen, H. et al., Protection of Vitamin E, Selenium, Torlox C, Ascorbic Acid Palmitate, Acetylcysteine, Coenzyme Q0, Coenzyme Q10, Beta-carotene Canthaxanthin, and (+)-Catechin Against Oxidative Damage to Rat Blood and Tissues In Vivo, abstract, Free Radical Bio. Med., 18(5) 1995.
Criares Theodore J.
University Technology Corporation
LandOfFree
Use of antioxidant agents to treat cholestatic liver disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of antioxidant agents to treat cholestatic liver disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of antioxidant agents to treat cholestatic liver disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1910730